Tue, March 5, 2013
Mon, March 4, 2013

Joseph Schwartz Initiated (SRPT) at Buy and Held Target at $45 on, Mar 5th, 2013

Joseph Schwartz of Leerink Swann, Initiated "Sarepta Therapeutics, Inc." (SRPT) at Buy and Held Target at $45 on, Mar 5th, 2013.

Joseph, nor any peers, have made any analyst calls on SRPT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30